Search Results

There are 51611 results for: content related to: Introductory Pharmacology for Clinical Practice

  1. Advances in Computational Prediction of Regioselective and Isoform-Specific Drug Metabolism Catalyzed by CYP450s.

    ChemistrySelect

    Volume 1, Issue 20, December 1, 2016, Pages: 6571–6597, Dr. Vaibhav A. Dixit and Dr. Shirish Deshpande

    Version of Record online : 15 DEC 2016, DOI: 10.1002/slct.201601051

  2. You have free access to this content
    Activation of microsomal cytochrome P450 mono-oxygenase by Ca2+ store depletion and its contribution to Ca2+ entry in porcine aortic endothelial cells

    British Journal of Pharmacology

    Volume 121, Issue 8, August 1997, Pages: 1579–1588, Bernhard G. Hoebel, Gert M. Kostner and Wolfgang F. Graier

    Version of Record online : 11 FEB 2009, DOI: 10.1038/sj.bjp.0701304

  3. Current and Future Tools for Predicting Clinical Drug–Drug Interactions

    Standard Article

    Encyclopedia of Drug Metabolism and Interactions

    Peter L. Bullock and Olga V. Trubetskoy

    Published Online : 15 OCT 2012, DOI: 10.1002/9780470921920.edm119

  4. Impact of age on hepatic cytochrome P450 of domestic male Camborough-29 pigs

    Journal of Veterinary Pharmacology and Therapeutics

    Volume 38, Issue 2, April 2015, Pages: 150–159, S. X. Hu

    Version of Record online : 17 SEP 2014, DOI: 10.1111/jvp.12163

  5. You have free access to this content
    The use of Yarrowia lipolytica for the expression of human cytochrome P450 CYP1A1

    Yeast

    Volume 21, Issue 7, May 2004, Pages: 583–592, M. B. Nthangeni, P. Urban, D. Pompon, M. S. Smit and J.-M. Nicaud

    Version of Record online : 30 APR 2004, DOI: 10.1002/yea.1127

  6. Modulation of Vascular O2 Responses by Cytochrome 450-4A ω-Hydroxylase Metabolites In Dahl Salt-Sensitive Rats

    Microcirculation

    Volume 16, Issue 4, May 2009, Pages: 345–354, JINGLI WANG, JAMES R. SCHMIDT, RICHARD J. ROMAN, SIDDAM ANJAIAH, JOHN R. FALCK and JULIAN H. LOMBARD

    Version of Record online : 26 JAN 2010, DOI: 10.1080/10739680802698007

  7. Changes in renal haemodynamics induced by indomethacin in the rat involve cytochrome P450 arachidonic acid-dependent epoxygenases

    Clinical and Experimental Pharmacology and Physiology

    Volume 31, Issue 10, October 2004, Pages: 683–690, N Caron, A El Hajjam, A-E Declèves, E Joly, JR Falck and R Kramp

    Version of Record online : 19 NOV 2004, DOI: 10.1111/j.0305-1870.2004.04066.x

  8. Arachidonic acid induces neuronal death through lipoxygenase and cytochrome P450 rather than cyclooxygenase

    Journal of Neuroscience Research

    Volume 81, Issue 1, 1 July 2005, Pages: 73–84, Kyoung Ja Kwon, Yi-Sook Jung, Soo Hwan Lee, Chang-Hyun Moon and Eun Joo Baik

    Version of Record online : 1 JUN 2005, DOI: 10.1002/jnr.20520

  9. Cytochrome P450 reaction phenotyping and inhibition and induction studies of pinostrobin in human liver microsomes and hepatocytes

    Biomedical Chromatography

    Shengnan Tan, Zhimin Dong, Jiashuo Zhang, Thomas Efferth, Yujie Fu and Xin Hua

    Version of Record online : 22 JAN 2017, DOI: 10.1002/bmc.3888

  10. Reductase-mediated metabolism of motexafin gadolinium (Xcytrin®) in rat and human liver subcellular fractions and purified enzyme preparations

    Journal of Pharmaceutical Sciences

    Volume 94, Issue 3, March 2005, Pages: 559–570, Chitra Mani, Shubhra Upadhyay, Steve Lacy, Garry W. Boswell and Dale R. Miles

    Version of Record online : 21 JAN 2005, DOI: 10.1002/jps.20274

  11. Cytochrome P450-Dependent Metabolites Of Arachidonic Acid And Renal Function In The Rat

    Clinical and Experimental Pharmacology and Physiology

    Volume 27, Issue 8, August 2000, Pages: 581–586, AO Oyekan

    Version of Record online : 24 DEC 2001, DOI: 10.1046/j.1440-1681.2000.03313.x

  12. An Evaluation of the Drug Interaction Potential of Pazopanib, an Oral Vascular Endothelial Growth Factor Receptor Tyrosine Kinase Inhibitor, Using a Modified Cooperstown 5+1 Cocktail in Patients With Advanced Solid Tumors

    Clinical Pharmacology & Therapeutics

    Volume 88, Issue 5, November 2010, Pages: 652–659, B C Goh, N J Reddy, U B Dandamudi, K H Laubscher, T Peckham, J P Hodge, A B Suttle, T Arumugham, Y Xu, C-F Xu, J Lager, M M Dar and L D Lewis

    Version of Record online : 29 SEP 2010, DOI: 10.1038/clpt.2010.158

  13. Expression of Cytochrome P450-4A Isoforms in the Rat Cremaster Muscle Microcirculation

    Microcirculation

    Volume 11, Issue 1, January-February 2004, Pages: 89–96, JINGLI WANG, KRISTOPHER G. MAIER, RICHARD J. ROMAN, LOURDES DE LA CRUZ, JIAXUAN ZHU, LISA HENDERSON and JULIAN H. LOMBARD

    Version of Record online : 26 JAN 2010, DOI: 10.1080/10739680490266225

  14. You have free access to this content
    Functional response of the rat kidney to inhibition of nitric oxide synthesis: role of cytochrome P450-derived arachidonate metabolites

    British Journal of Pharmacology

    Volume 125, Issue 5, November 1998, Pages: 1065–1073, Adebayo O. Oyekan and J. C. McGiff

    Version of Record online : 11 FEB 2009, DOI: 10.1038/sj.bjp.0702171

  15. You have free access to this content
    Inter-individual variability in levels of human microsomal protein and hepatocellularity per gram of liver

    British Journal of Clinical Pharmacology

    Volume 56, Issue 4, October 2003, Pages: 433–440, Z. E. Wilson, A. Rostami-Hodjegan, J. L. Burn, A. Tooley, J Boyle, S. W. Ellis and G. T. Tucker

    Version of Record online : 20 AUG 2003, DOI: 10.1046/j.1365-2125.2003.01881.x

  16. You have full text access to this OnlineOpen article
    Physiologically Based Pharmacokinetic Model to Assess the Influence of Blinatumomab-Mediated Cytokine Elevations on Cytochrome P450 Enzyme Activity

    CPT: Pharmacometrics & Systems Pharmacology

    Volume 4, Issue 9, September 2015, Pages: 507–515, Y Xu, Y Hijazi, A Wolf, B Wu, Y-N Sun and M Zhu

    Version of Record online : 22 AUG 2015, DOI: 10.1002/psp4.12003

  17. You have free access to this content
    Contribution of cytochrome P450 metabolites to bradykinin-induced vasodilation in endothelial NO synthase deficient mouse hearts

    British Journal of Pharmacology

    Volume 135, Issue 3, February 2002, Pages: 631–638, Zhaoping Ding, Axel Gödecke and Jürgen Schrader

    Version of Record online : 2 FEB 2009, DOI: 10.1038/sj.bjp.0704472

  18. Prevalence of Exposure to Potential CYP450 Pharmacokinetic Drug–Drug Interactions among Patients with Chronic Low Back Pain Taking Opioids

    Pain Practice

    Volume 11, Issue 3, May/June 2011, Pages: 230–239, Joseph V. Pergolizzi, Jr., Sumedha A. Labhsetwar, R. Amy Puenpatom, Seongjung Joo, Rami H. Ben-Joseph and Kent H. Summers

    Version of Record online : 26 AUG 2010, DOI: 10.1111/j.1533-2500.2010.00413.x

  19. Opioid Metabolism and Effects of Cytochrome P450

    Pain Medicine

    Volume 10, Issue s1, April 2009, Pages: S20–S29, Gregory L. Holmquist

    Version of Record online : 1 APR 2009, DOI: 10.1111/j.1526-4637.2009.00596.x

  20. A rapid ultra-performance liquid chromatography/tandem mass spectrometric methodology for the in vitro analysis of Pooled and Cocktail cytochrome P450 assays

    Rapid Communications in Mass Spectrometry

    Volume 24, Issue 1, 15 January 2010, Pages: 147–154, Peter G. Alden, Robert S. Plumb, Michael D. Jones, Paul D. Rainville and Darcy Shave

    Version of Record online : 3 DEC 2009, DOI: 10.1002/rcm.4364